Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

Illumina (ILMN) and Tempus AI (TEM) announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. The collaboration will combine ...

The base and pessimistic DCF models implemented in this article suggest that Illumina is undervalued. Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. The DNA ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of ...

According to Kiss, the system’s $1,100 per-run operating cost — $500 less than the university’s existing Illumina MiSeq system — will make it more accessible to Miami researchers and graduate students ...

A congressional transaction is when any representative or senator either buys or sells an individual stock. Anyone working in Congress must file a Periodic Transaction Report to inform the public ...

Nano-X just won FDA approval to generate 3D X-ray images with its Nanox.ARC X machines. Nano-X is not yet profitable and continues to burn cash. At current burn rates, the company could be out of ...

In the preceding three months, 14 analysts have released ratings for Illumina ILMN, presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their ...